Potential role of Jun activation domain-binding protein 1 and phosphorylated p27 expression in prognosis of glioma

Brain Tumor Pathology

Volumn 29, Issue 1, 2012, Pages 3-9

  He, Shi Ming ^a   Zhao, Zhen Wei ^a   Wang, Yuan ^a   Zhao, Ji Pei ^a   Wang, Liang ^a   Hou, Fang ^a   Gao, Guo Dong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Jun activation domain binding protein 1; P27; Phosphorylation; Prognosis

Indexed keywords

BINDING PROTEIN; JUN ACTIVATION DOMAIN BINDING PROTEIN 1; PROTEIN P27; SERINE; UNCLASSIFIED DRUG; COPS5 PROTEIN, HUMAN; CYCLINE; P27 ANTIGEN; PEPTIDE HYDROLASE; SIGNAL PEPTIDE; TUMOR MARKER;

ADULT; ARTICLE; BRAIN BIOPSY; CANCER PROGNOSIS; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STATISTICAL ANALYSIS; BIOSYNTHESIS; BRAIN TUMOR; CANCER GRADING; METABOLISM; MIDDLE AGED; MORTALITY; PHOSPHORYLATION; PROGNOSIS;

ADULT; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; PEPTIDE HYDROLASES; PHOSPHORYLATION; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860634020     PISSN: 14337398     EISSN: 1861387X     Source Type: Journal    
DOI: 10.1007/s10014-011-0061-1     Document Type: Article

References (23)

1. Surawicz TS, Davis F, Freels S, Laws ER Jr, Menck HR (1998) Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 40:151-160 (Pubitemid 29010168)
2. Kallio M, Sankila R, Jääskeläinen J, Karjalainen S, Hakulinen T (1991) A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984. Cancer (Phila) 68:1394-1400
3. Qi CF, Xiang S, Shin MS, Hao X, Lee CH, Zhou JX, Torrey TA, Hartley JW, Fredrickson TN, Morse HC III (2006) Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas. Leuk Res 30:153-163 (Pubitemid 41773335)
4. Jeon JH, Lee KN, Hwang CY, Kwon KS, You KH, Choi I (2005) Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Cancer Res 65:4485-4489 (Pubitemid 40740780)
5. Cope GA, Deshaies RJ (2006) Targeted silencing of Jab1/Csn5 in human cells downregulates SCF activity through reduction of F-box protein levels. BMC Biochem 7:1
6. Esteva FJ, Sahin AA, Rassidakis GZ, Yuan LX, Smith TL, Yang Y, Gilcrease MZ, Cristofanilli M, Nahta R, Pusztai L, Claret FX (2003) Jun activation domain binding protein 1 expression is associated with low p27 (Kip1) levels in node-negative breast cancer. Clin Cancer Res 9:5652-5659 (Pubitemid 37499487)
7. Wang Y, Wang Y, Cheng C, Ji Y, Zhao Y, Zou L, Shen A (2009) Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma. J Cancer Res Clin Oncol 135:951-959
8. Osoegawa A, Yoshino I, Kometani T, Yamaguchi M, Kameyama T, Yohena T, Maehara Y (2006) Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features. Cancer (Phila) 107:154-161 (Pubitemid 43939042)
9. Qin J, Wang Z, Wang Y, Ma L, Ni Q, Ke J (2010) JAB1 expression is associated with inverse expression of p27(kip1) in hepatocellular carcinoma. Hepatogastroenterology 57:547-553
10. Wang Y, Fei M, Cheng C, Zhang D, Lu J, He S, Zhao Y, Wang Y, Shen A (2008) Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas. Cancer Biol Ther 7:460-467 (Pubitemid 351847068)
11. Kouvaraki MA, Rassidakis GZ, Tian L, Kumar R, Kittas C, Claret FX (2003) Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27 (Kip1). Cancer Res 63:2977-2981 (Pubitemid 36667172)
12. Kouvaraki MA, Korapati AL, Rassidakis GZ, Tian L, Zhang Q, Chiao P, Ho L, Evans DB, Claret FX (2006) Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma. Cancer Res 66:8581-8589 (Pubitemid 44449172)
13. Shintani S, Li C, Mihara M, Hino S, Nakashiro K, Hamakawa H (2003) Skp2 and Jab1 expression are associated with inverse expression of p27 (KIP1) and poor prognosis in oral squamous cell carcinomas. Oncology 65:355-362 (Pubitemid 38064948)
14. Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y, Tokuda M (2001) Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin Cancer Res 7:4130-4135 (Pubitemid 34044637)
15. Rodier G, Montagnoli A, Di Marcotullio L, Coulombe P, Draetta GF, Pagano M, Meloche S (2001) p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J 20:6672-6682 (Pubitemid 33134197)
16. Ishida N, Hara T, Kamura T (2002) Phosphorylation of p27kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem 277:14355-14358 (Pubitemid 34952496)
17. Ishida N, Kitagawa M, Hatakeyama S (2000) Phosphorylation at serine 10, a major phosphorylation site of p27 (Kip1), increases its protein stability. J Biol Chem 275:25146-25154
18. Ahn J, Hong SA, Lee SE, Kim J, Oh YS, Park SJ, Chung YJ (2009) Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma. Endocr J 56:707-713
19. Shiraso S, Katayose Y, Yamamoto K, Mizuma M, Yabuuchi S, Oda A, Rikiyama T, Onogawa T, Yoshida H, Hayashi H, Ohtsuka H, Motoi F, Egawa S, Kato J, Unno M (2009) Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth. Anticancer Res 29:2015-2024
20. Yachida S, Imaida K, YokohiraM, Hashimoto N, Suzuki S, Okano K, Wakabayashi H, Maeta H, Suzuki Y (2010) Jun activation domain binding protein 1 is overexpressed from the very early stages of hepatocarcinogenesis. Ann Surg Oncol 17:3386-3393
21. Chen L, Yuan D, Wang GL, Wang Y, Wu YY, Zhu J (2010) Clinicopathological significance of expression of Tspan-1, Jab1 and p27 in human hepatocellular carcinoma. J Korean Med Sci 25:1438-1442
22. Wu FY, Wang SE, Sanders ME, Shin I, Rojo F, Baselga J, Arteaga CL (2006) Reduction of cytosolic p27 (Kip1) inhibits cancer cell motility, survival, and tumorigenicity. Cancer Res 66:2162-2172
23. Yang J, Liao D, Wang Z, Liu F, Wu G (2011) Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients' prognosis. J Surg Res 168:97-102